MucoUp® as a spacer in brachytherapy for uterine cervical cancer: A first-in-human experience

We first used MucoUp®, a hyaluronic acid used in endoscopic resection, as a spacer in brachytherapy. In five cervical cancer patients, MucoUp® insertion increased a 90% dose of the high-risk CTV to over 80 Gy while decreasing the dose of organs at risk. No related adverse events were observed.

Bibliografski detalji

Glavni autori:	Yoichi Muramoto, Naoya Murakami, Tatsuki Karino, Satoru Sugimoto, Jun Takatsu, Masaki Oshima, Yasuo Kosugi, Terufumi Kawamoto, Takashi Hirayama, Kazunari Fujino, Yasuhisa Terao, Naoto Shikama
Format:	Artigo
Jezik:	Inglês
Izdano:	Elsevier 2023-09-01
Serija:	Clinical and Translational Radiation Oncology
Teme:	Brachytherapy Uterine cervical cancer Spacer MucoUp®
Online pristup:	http://www.sciencedirect.com/science/article/pii/S2405630823000848
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!